Phagocyte Biology Laboratory

Dr. Bryan Heit, Western University

About Us

Welcome! You have reached the homepage for the laboratory of Dr. Bryan Heit. Our lab is part of the Department of Microbiology and Immunology at Western University, and we are members of the Center for Human Immunology, the lead centre for the CIHR Human Immunology Network.

Our interests surround the function of phagocytes – white blood cells which ingest (phagocytose) pathogens, particles, and dead cells. We focus on the cellular and molecular processes which control the function of these cells during the maintenance of homeostasis, infection and chronic inflammatory disease. Central to most of our studies is the study of efferoctyosis – the phagocytic removal of apoptotic (dying) cells, and how failures in this process lead to inflammation, autoimmunity and infection.

What is a Phagocyte?

Phagocytes are a class of white blood cells which have the capacity to engulf large particles such as bacterial and fungal pathogens, and subsequently destroy the engulfed material. The term phagocyte literally translates to “cell that eats”, which is an apt description of the primary function of these cells in our bodies. While there are many types of phagocytes, the Heit lab focuses primarily on macrophages, which play key roles in both maintaining our bodies and in fighting infections.

Lab News

Rab17 and Antigen Fate

Rab17 Abstract2017 in nearly upon us, but the Heit lab was able to squeeze out one last paper in 2016. This is an exciting moment for our lab, as this study was the major focus of our work for nearly five years. Our goal in this study was to understand how macrophages decide how to respond to the different types of targets they encounter in tissues. This decision-making process is coordinated by Rab17, which selectively diverts non-infectious materials away from parts of the macrophage used to initiate anti-pathogen immune responses.

This decision making process is a key function of macrophages, as these cells are tasked with both “housekeeping duties” (e.g. removing the dead and dying cells that form normally in our bodies) and with anti-pathogen defence. Both dying self-cells and pathogens are internalized and degraded by macrophages, and it is at this point that macrophages need to make a key decision – whether to present these degraded materials to other immune cells, thus activating a broader immune response. Making this decision correctly is critically important as presenting degraded self-cells to your immune system may lead to an autoimmune disease such as multiple sclerosis or rheumatoid arthritis, whereas failing to present a degraded pathogen may enable infection.

How this “decision” is made was not clear – until now. By recovering macrophage vacuoles containing beads which mimicked either dead cells or pathogens, and then using mass spectrometry to identify the proteins present on each vacuole, we were able to identify the protein Rab17 as a protein selectively recruited to the dead cell-containing vacuole. Microscopy-based studies then determined that this protein directs degraded dead cell materials to an organelle called the “recycling endosome”, where that material is either absorbed or expelled by the macrophage. Rab17 does not accumulate on pathogen-containing vacuoles, thereby preventing recycling of degraded pathogens. Instead, degraded pathogens are trafficked to a different organelle, where they are loaded on the MHC II molecules that present the degraded pathogen to the immune system.

Reference: Yin C, Kim Y, Argintaru D, Heit B. Rab17 mediates differential antigen sorting following efferocytosis and phagocytosis. Cell Death and Disease. 2016 Dec 22;7(12):e2529. [PubMed][Article]

HIV Immunevasion

HIV We are excited to announce the publication of a collaborative study, investigating one mechanism which is used by HIV to evade the immune system. This study, a product of our long-standing collaboration with Jimmy Dikeako’s lab at Western University, discovered that the HIV protein Nef sequesters a key component of the immune system (MHC I) inside the cell. MHC I normally acts to present small fragments of pathogens such as HIV to immune cells, thereby allowing the immune system to identify and remove infected cells. By sequestering MHC I inside of infected cells, HIV “blinds” the immune system to its presence, allowing its infection to go unchecked.

This study builds upon the two previous collaborative studies produced by the Heit and Dikeakos lab – our initial description of the interaction between Nef and host cell proteins, and our development of new analysis methods for super-resolution microscopy.

Dirk BS, Pawlak EN, Johnson AL, Van Nynatten LR, Jacob RA, Heit B, Dikeakos JD. HIV-1 Nef sequesters MHC-I intracellularly by targeting early stages of endocytosis and recycling. Scientific Reports. 2016 Nov 14;6:37021. [Pubmed] [Article]

Efferocytosis Assays

quantitative efferocytosis assaysThe Heit lab is excited to announce our latest publication titled Quantitative Efferocytosis Assays, and published in Methods in Molecular Biology [Pubmed] [Article]. This paper describes many of the microscopy and cell based methods we use to study efferocytosis – the processes by which cells such as macrophages identify, engage, engulf and destroy dying (apoptotic) cells.

Efferocytosis plays a key role in maintaining homeostasis. The normal turnover of cells produces tens of billions of dying cells every day which must be removed. During times of injury or infection, the numbers of dying cells generated in our body can reach astronomical proportions, with some studies estimating that as many as 100 billion dying cells are produced daily during these events. Defects in efferocytosis leads to a range of clinical conditions including inflammatory diseases such as atherosclerosis, and autoimmune diseases such as multiple sclerosis. The clinical burden and cost of these diseases is immense, as is the human toll they impart, and as a consequence, understanding efferocytosis is paramount for reducing the burden of these diseases.

A range of methods can be found in this paper, including techniques to prepare and label synthetic targets which mimic dying cells, techniques to prepare and label dying cells such that they are compatible with a range of assays, and techniques to quantify the efferocytic efficiency, and methods to assess the processing of these efferocytic targets, all using a variety of microscopy techniques.

Many of these methods are derived from classical assays for quantifying phagocytosis, the removal and destruction of pathogens by immune cells. Because of this classical basis, many of these methods can be easily employed in most labs without the need for advanced cell processing or microscopy equipment. However, these methods can be combined with advanced live-cell fluorescence microscopy and even super-resolution microscopy, enabling their use in experiments reliant on leading-edge technologies. The methods described in this paper are applicable to a broad range of research questions and investigative approaches, and can be deployed in most labs.

Reference:

Evans AL, Blackburn JW, Yin C, Heit B. Quantitative Efferocytosis Assays. Methods in Molecular Biology: Phagocytosis and Phagosomes. 2017;1519:25-41. [Pubmed] [Article]

Announcing the RGE Murray Lecturer

RGE Lecturer - Dr. Chris Glass

Dr. Chris Glass

We are excited to announce the 2016/2017 RGE Murray Lecturer, Dr. Chris Glass, Professor of Cellular and Molecular Medicine and Professor of Medicine at the University of California, San Diego School of Medicine. Dr. Glass is a leader in the field of macrophage biology, and has made many seminar discoveries regarding the differentiation and specialisation of macrophages in response to various immunological stimuli and tissue environments.

Dr. Glass has published over 275 scientific papers, many in leading journals including Nature, Nature Immunology, eLife and Cell. Dr. Glass has been elected to the American Academy of Arts and Sciences (2014) and to the American Academy of Medicine (2015). He will be visiting Western University on January 27th, 2017. The time and location of his talk will be announced at a later date.

The RGE Murray Annual Lecture Seminar Series is supported by a generous donation made in the name of Professor Emeritus Robert G.E. Murray, and brings world leading immunologists, virologists and microbiologists to Western University. Dr. Murray served as department chair (1949 – 1974), is a founder of Canadian Society of Microbiologists, and in 1998 was invested into the Order of Canada in acknowledgement of his many contributions to science and the scientific community.

Twitter Feed

Here's what some of the people we follow are saying:

Upcoming Events

January 6th 2017

Microbiology & Immunology 3300 - Immunology begins!


January 19th 2017
RGE Murray Seminar Series - Dr. Byram Bridle, Univeristy of Guelph


January 26th 2017
RGE Murray Seminar Series - Dr. Andrew Redd, John Hopkins


January 27th 2017
RGE Murray Seminar Series - RGE Murray Lectureship - Dr.Christopher Glass, University of California (San Diego)


February 2nd 2017
RGE Murray Seminar Series - Dr. Greg Gloor, Western University


February 16th 2017
RGE Murray Seminar Series - Dr. Rajesh Jacob, Western University


February 23rd 2017
RGE Murray Seminar Series - Dr. David Brooks, Princess Margaret Cancer Centre


WordPress Appliance - Powered by TurnKey Linux